The Medicity, Gurgaon, consistently ranked India’s Best Private Hospital by Newsweek for six consecutive years, today reaffirmed its commitment to delivering world-class healthcare through cutting-edge treatments in cardiology and nephrology. The announcement was made during a special session in Itanagar, where senior Medanta experts highlighted new clinical approaches to tackling coronary artery disease (CAD), valvular heart disease (VHD), and complex Cardio-Renal-Hepatic-Diabetic Metabolic Syndrome (CRHD-MS).
Dr. Praveen Chandra, Chairman, Interventional Cardiology, introduced next-generation options including robotic-assisted cardiac procedures, minimally invasive valve surgeries, TAVR, and hybrid angioplasty techniques. He emphasized the importance of early diagnosis in achieving better outcomes and reducing long-term treatment costs.
Dr. Debabrata Mukherjee, Senior Director of Nephrology, underscored the economic and health burden of interconnected cardiac, kidney, and metabolic disorders, calling for integrated care models to improve patient outcomes and community health standards. Founded by renowned cardiac surgeon Dr. Naresh Trehan, Medanta currently operates five hospitals and is expanding its network in Noida, Delhi, Mumbai, and Guwahati.
